1HLA
| STRUCTURE OF THE HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 | 分子名称: | BETA 2-MICROGLOBULIN, CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA-A2) (ALPHA CHAIN) | 著者 | Bjorkman, P.J, Saper, M.A, Samraoui, B, Bennett, W.S, Strominger, J.L, Wiley, D.C. | 登録日 | 1987-10-15 | 公開日 | 1988-01-16 | 最終更新日 | 2024-02-07 | 実験手法 | X-RAY DIFFRACTION (3.5 Å) | 主引用文献 | Structure of the human class I histocompatibility antigen, HLA-A2. Nature, 329, 1987
|
|
1CWV
| |
3HLA
| |
1A6Z
| HFE (HUMAN) HEMOCHROMATOSIS PROTEIN | 分子名称: | BETA-2-MICROGLOBULIN, HFE | 著者 | Lebron, J.A, Bennett, M.J, Vaughn, D.E, Chirino, A.J, Snow, P.M, Mintier, G.A, Feder, J.N, Bjorkman, P.J. | 登録日 | 1998-03-04 | 公開日 | 1999-03-23 | 最終更新日 | 2023-08-02 | 実験手法 | X-RAY DIFFRACTION (2.6 Å) | 主引用文献 | Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell(Cambridge,Mass.), 93, 1998
|
|
1BIH
| CRYSTAL STRUCTURE OF THE INSECT IMMUNE PROTEIN HEMOLIN: A NEW DOMAIN ARRANGEMENT WITH IMPLICATIONS FOR HOMOPHILIC ADHESION | 分子名称: | HEMOLIN, PHOSPHATE ION | 著者 | Su, X.-D, Gastinel, L.N, Vaughn, D.E, Faye, I, Poon, P, Bjorkman, P.J. | 登録日 | 1998-06-17 | 公開日 | 1998-10-14 | 最終更新日 | 2018-03-07 | 実験手法 | X-RAY DIFFRACTION (3.1 Å) | 主引用文献 | Crystal structure of hemolin: a horseshoe shape with implications for homophilic adhesion. Science, 281, 1998
|
|
8D5C
| anti-HIV-1 gp120-sCD4 complex antibody CG10 Fab in complex with B41-sCD4 | 分子名称: | CG10 Fab heavy chain, CG10 Fab light chain, Envelope glycoprotein gp160, ... | 著者 | Yang, Z, Bjorkman, P.J, Gershoni, J.M. | 登録日 | 2022-06-04 | 公開日 | 2022-11-16 | 最終更新日 | 2023-01-04 | 実験手法 | ELECTRON MICROSCOPY (3.9 Å) | 主引用文献 | Antibody Recognition of CD4-Induced Open HIV-1 Env Trimers. J.Virol., 96, 2022
|
|
8D54
| |
3FRU
| NEONATAL FC RECEPTOR, PH 6.5 | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, BETA-2-MICROGLOBULIN, BETA-MERCAPTOETHANOL, ... | 著者 | Vaughn, D.E, Burmeister, W.P, Bjorkman, P.J. | 登録日 | 1997-12-22 | 公開日 | 1998-06-10 | 最終更新日 | 2020-07-29 | 実験手法 | X-RAY DIFFRACTION (2.2 Å) | 主引用文献 | Structural basis of pH-dependent antibody binding by the neonatal Fc receptor. Structure, 6, 1998
|
|
2VSD
| crystal structure of CHIR-AB1 | 分子名称: | CHIR AB1, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose | 著者 | Arnon, T.I, Kaiser, J.T, Bjorkman, P.J. | 登録日 | 2008-04-22 | 公開日 | 2008-07-29 | 最終更新日 | 2023-12-13 | 実験手法 | X-RAY DIFFRACTION (1.82 Å) | 主引用文献 | The Crystal Structure of Chir-Ab1: A Primordial Avian Classical Fc Receptor. J.Mol.Biol., 381, 2008
|
|
8FYJ
| Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I) | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Envelope glycoprotein gp160, ... | 著者 | Fan, C, Dam, K.A, Bjorkman, P.J. | 登録日 | 2023-01-26 | 公開日 | 2023-10-18 | 最終更新日 | 2023-12-13 | 実験手法 | ELECTRON MICROSCOPY (4 Å) | 主引用文献 | Intermediate conformations of CD4-bound HIV-1 Env heterotrimers. Nature, 623, 2023
|
|
8FYI
| Structure of HIV-1 BG505 SOSIP-HT1 in complex with one CD4 molecule | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(6-8)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Fan, C, Dam, K.A, Bjorkman, P.J. | 登録日 | 2023-01-26 | 公開日 | 2023-10-18 | 最終更新日 | 2023-12-13 | 実験手法 | ELECTRON MICROSCOPY (3.4 Å) | 主引用文献 | Intermediate conformations of CD4-bound HIV-1 Env heterotrimers. Nature, 623, 2023
|
|
2PZX
| Structure of the methuselah ectodomain with peptide inhibitor | 分子名称: | G-protein coupled receptor Mth | 著者 | West Jr, A.P, Ja, W.W, Delker, S.L, Bjorkman, P.J, Benzer, S, Roberts, R.W. | 登録日 | 2007-05-18 | 公開日 | 2007-08-28 | 最終更新日 | 2023-08-30 | 実験手法 | X-RAY DIFFRACTION (3.5 Å) | 主引用文献 | Extension of Drosophila melanogaster life span with a GPCR peptide inhibitor. Nat.Chem.Biol., 3, 2007
|
|
1OW0
| Crystal structure of human FcaRI bound to IgA1-Fc | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Ig alpha-1 chain C region, Immunoglobulin alpha Fc receptor, ... | 著者 | Herr, A.B, Ballister, E.R, Bjorkman, P.J. | 登録日 | 2003-03-27 | 公開日 | 2003-05-27 | 最終更新日 | 2023-08-16 | 実験手法 | X-RAY DIFFRACTION (3.1 Å) | 主引用文献 | Insights into IgA-mediated immune responses from the crystal structures of human Fc-alpha-RI and its complex with IgA1-Fc Nature, 423, 2003
|
|
1OVZ
| Crystal structure of human FcaRI | 分子名称: | 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | 著者 | Herr, A.B, Ballister, E.R, Bjorkman, P.J. | 登録日 | 2003-03-27 | 公開日 | 2003-05-27 | 最終更新日 | 2020-07-29 | 実験手法 | X-RAY DIFFRACTION (3 Å) | 主引用文献 | Insights into IgA-mediated immune responses from the crystal structures of human Fc-alpha-RI and its complex with IgA1-Fc Nature, 423, 2003
|
|
3D2U
| Structure of UL18, a Peptide-Binding Viral MHC Mimic, Bound to a Host Inhibitory Receptor | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Actin, Beta-2-microglobulin, ... | 著者 | Yang, Z, Bjorkman, P.J. | 登録日 | 2008-05-08 | 公開日 | 2008-07-08 | 最終更新日 | 2023-08-30 | 実験手法 | X-RAY DIFFRACTION (2.21 Å) | 主引用文献 | Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor Proc.Natl.Acad.Sci.Usa, 105, 2008
|
|
3IT8
| |
6XCM
| |
6XCA
| Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C105 | 分子名称: | C105 Heavy Chain, C105 Light Chain, SULFATE ION | 著者 | Sharaf, N.G, Barnes, C.O, Bjorkman, P.J. | 登録日 | 2020-06-08 | 公開日 | 2020-07-01 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies. Cell, 182, 2020
|
|
6XCN
| |
5IGX
| |
5I9Q
| Crystal structure of 3BNC55 Fab in complex with 426c.TM4deltaV1-3 gp120 | 分子名称: | 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, 3BNC55 Fab heavy chain, ... | 著者 | Scharf, L, Chen, C, Bjorkman, P.J. | 登録日 | 2016-02-20 | 公開日 | 2016-05-04 | 最終更新日 | 2023-09-27 | 実験手法 | X-RAY DIFFRACTION (3 Å) | 主引用文献 | Structural basis for germline antibody recognition of HIV-1 immunogens. Elife, 5, 2016
|
|
7N3E
| Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment C032 | 分子名称: | C032 Fab Heavy Chain, C032 Fab Light Chain | 著者 | Flyak, A.I, Bjorkman, P.J, Barnes, C.O. | 登録日 | 2021-06-01 | 公開日 | 2021-08-04 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (2.06 Å) | 主引用文献 | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity, 54, 2021
|
|
7N3G
| Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment C098 | 分子名称: | C098 Fab Heavy Chain, C098 Fab Light Chain | 著者 | Flyak, A.I, Bjorkman, P.J, Barnes, C.O. | 登録日 | 2021-06-01 | 公開日 | 2021-08-04 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.42 Å) | 主引用文献 | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity, 54, 2021
|
|
7N3H
| Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment C099 | 分子名称: | C099 Fab Heavy Chain, C099 Fab Light Chain | 著者 | Flyak, A.I, Bjorkman, P.J, Barnes, C.O. | 登録日 | 2021-06-01 | 公開日 | 2021-08-04 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.26 Å) | 主引用文献 | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity, 54, 2021
|
|
7N3F
| Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment C080 | 分子名称: | C080 Fab Heavy Chain, C080 Fab Light Chain | 著者 | Flyak, A.I, Bjorkman, P.J, Barnes, C.O. | 登録日 | 2021-06-01 | 公開日 | 2021-08-04 | 最終更新日 | 2023-10-18 | 実験手法 | X-RAY DIFFRACTION (1.9 Å) | 主引用文献 | Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity, 54, 2021
|
|